WisPaper
WisPaper
Search
Assistant
Pricing
TrueCite

Does CT radiation exposure significantly increase lifetime cancer risk?

CT radiation exposure does increase lifetime cancer risk, but the absolute risk for an individual is small, especially compared to the benefits of a medically necessary scan.

Direct answer

Yes, CT radiation exposure does increase lifetime cancer risk, but the increase is small for an individual. The evidence shows a clear dose-response relationship: the more radiation you receive, the higher your risk. For example, one large study found that for every 1,000 mGy*cm increase in radiation dose, the risk of developing a new cancer went up by 8% [1]. However, the absolute risk is low; a typical CT scan of the abdomen and pelvis carries a lifetime cancer risk of about 0.03% (or 3 in 10,000) [7], and for children, the estimated risk from a single CT scan is about 1 in 10,000 [8]. Across the studies here, the larger and more rigorous trials consistently show this small but real increase in risk, particularly for children and for cancers of the brain and blood-forming tissues [4][5].

10sources cited

This article was generated with WisPaper-powered search and paper analysis.

Does CT radiation really cause cancer? The short answer is yes, but the risk is small.

The evidence is now strong enough to say that CT scans can cause cancer. A 2021 review of 17 epidemiological studies found that seven out of eight studies on leukemia and six out of seven studies on brain tumors reported a positive dose-response relationship — meaning the more radiation exposure, the higher the risk [5]. This is not a theoretical concern; it is based on real-world data from hundreds of thousands of patients. For example, a 2022 French study of children who had CT scans found a statistically significant increase in brain tumors and leukemia with increasing radiation dose to the brain and bone marrow [4]. The risk is real, but it is also small. The same review concluded that 'the absolute risks to individual patients are likely to be small' [5].

To put the numbers in perspective: a typical CT scan of the kidneys, ureters, and bladder (CT-KUB) carries a lifetime cancer risk of about 0.03% (3 in 10,000) [7]. A CT scan of the abdomen and pelvis gives a similarly low risk — about 2 extra cases of prostate or uterine cancer per 100,000 people [10]. Even for children, who are more sensitive to radiation, the estimated lifetime risk from a single CT scan is about 1 in 10,000 [8]. These are not zero, but they are very small compared to the average person's lifetime risk of developing cancer from all causes, which is about 40% [8].

Children are more vulnerable, but the risk is still manageable.

Children are more sensitive to radiation because their cells are dividing more rapidly and they have more years of life ahead for a cancer to develop. A 2025 study estimated that the radiation from CT scans performed annually on children in the U.S. is associated with about 5,500 future cancers [2]. This sounds alarming, but it must be seen in context: millions of CT scans are performed on children each year, and the vast majority of those children will not get cancer from the scan. The same study found that differences in radiation doses between hospitals (some using 20-30% higher doses) could account for about 1,200 of those cancers, suggesting that dose optimization could significantly reduce risk [2].

The risk for children is also supported by the French CT cohort study, which found that for every 10 mGy of radiation to the brain, the risk of a brain tumor increased by 5%, and for every 10 mGy to the bone marrow, the risk of leukemia increased by 17% [4]. These are relative risk increases, not absolute ones. To make this concrete: a typical head CT delivers about 40-60 mGy to the brain, so the relative risk increase would be about 20-30%, but the absolute risk of a child developing a brain tumor from that scan is still very small — on the order of 1 in 10,000 [8].

For a medically necessary scan, the benefits far outweigh the small cancer risk.

It is crucial to understand that the cancer risk from a single CT scan is tiny compared to the potential benefit of an accurate diagnosis. For example, lung cancer screening with low-dose CT in heavy smokers reduces lung cancer mortality by about 20%, while the radiation-related cancer risk is estimated at less than 0.25% for women and 0.1% for men — a benefit-risk ratio of 10 to 25 to one [6]. In other words, for every person who might theoretically get cancer from the screening, 10 to 25 people will have their lives saved from lung cancer.

The same logic applies to diagnostic CT scans. A 2023 study found that among patients who had a CT scan for a suspected pulmonary embolism (a blood clot in the lung), there was no significant difference in cancer risk compared to patients who had a different type of scan (VQ scan) that uses less radiation [3]. This suggests that the underlying condition being investigated — not the scan itself — may be a more important driver of cancer risk. The authors of a 2021 review on CT and cancer risk put it plainly: 'the benefits of an appropriately indicated and timely done CT have far outweighed the risks involved' [8].

The key is to avoid unnecessary scans. A 2023 study found that 67.5% of head CT scans performed in one emergency department were normal — meaning no abnormality was found [9]. These scans delivered radiation with no clinical benefit. The same study estimated that these normal scans could lead to about 8 extra cancers per 100,000 patients [9]. This is why guidelines emphasize the 'as low as reasonably achievable' (ALARA) principle: every CT should be justified by a clear medical need, and the dose should be optimized for the patient's size and age [8].

About These Sources

This answer is built on 10 peer-reviewed studies — published from 2021 to 2026, 3 from 2024 or later, 6 in Q1 journals, collectively cited 141 times — selected as the most relevant from 12 studies that passed quality screening, drawn from 67 papers retrieved from a database of over 500 million.

Sources used in this answer

1

Dose-related association between radiation exposure from computed tomography (CT) scans during trauma hospitalizations and subsequent risk of developing new-onset cancers

In a statewide cohort study of adult trauma patients, each 1,000 mGy*cm increase in CT radiation dose was associated with an 8% increase in the risk of developing a new cancer, and those exposed to very high doses (>5,000 mGy*cm) had a 3.35 times higher risk of cancer-related death [1].

2

Cancer Risk Associated With Radiation Doses Used for CT Scans in Pediatric and General Hospitals.

A retrospective cohort study of children under 21 found that radiation doses from pediatric CT scans are associated with an estimated 5,500 future cancers annually in the U.S., with dose differences between hospitals accounting for about 1,200 of those cancers [2].

3

Comparative analysis of radiation exposure from computed tomography and ventilation-perfusion scans in the diagnosis of pulmonary embolism: an early-onset cancer risk assessment

In a population-based matched cohort study of 20,476 patients diagnosed with pulmonary embolism, there was no significant difference in cancer risk between those who had a CT pulmonary angiogram (CTPA) and those who had a ventilation-perfusion (VQ) scan, suggesting the underlying condition may be a more important risk factor [3].

4

Childhood cancer risks estimates following CT scans: an update of the French CT cohort study

An updated French cohort study of children who had CT scans found a statistically significant dose-response relationship: for every 10 mGy of radiation to the brain, the risk of a brain tumor increased by 5%, and for every 10 mGy to the bone marrow, the risk of leukemia increased by 17% [4].

5

Epidemiological studies of CT scans and cancer risk: the state of the science

A review of 17 epidemiological studies found that 7 of 8 studies on leukemia and 6 of 7 studies on brain tumors reported a positive dose-response relationship with CT radiation, with a meta-analysis showing a summary excess relative risk of 1.78 per 100 mGy for leukemia and 0.80 per 100 mGy for brain tumors [5].

6

Lung Cancer Screening with Low-Dose CT: Radiation Risk and Benefit–Risk Assessment for Different Screening Scenarios

For annual low-dose CT lung cancer screening in heavy smokers aged 50-75, the estimated radiation-related lifetime cancer risk is below 0.25% for women and 0.1% for men, while the mortality reduction from screening is about 20%, yielding a benefit-risk ratio of about 10-25 to 1 [6].

7

Assessment of effective dose and radiation-induced cancer risk in CT-KUB

A study of 110 patients undergoing CT-KUB (kidneys, ureters, bladder) found a mean effective dose of 5.8 mSv and a lifetime cancer risk ranging from 0.01% to 0.08%, with a mean of 0.03% per 100,000 procedures [7].

8

Cancer risk of CT scan in COVID-19

A review on CT and COVID-19 concluded that there is no conclusive evidence of cancer caused by low-level radiation (<50-100 mSv) from medical imaging, but emphasized the ALARA principle (justification and optimization) to avoid unnecessary scans [9].

9

Evaluation of Cancer Risk Induced by Radiation Exposure from Normal Head CT Scans

A study of 400 head CT scans in an emergency department found that 67.5% were normal (no abnormality), and estimated that these unnecessary scans could lead to about 8 extra solid cancers and 0.7 extra leukemia cases per 100,000 patients [10].

10

Estimation of radiation doses and lifetime attributable risk of radiation-induced cancer in the uterus and prostate from abdomen pelvis CT examinations

A study of 665 patients undergoing abdomen-pelvis CT found mean organ doses of 10.86 mGy to the uterus and 7.00 mGy to the prostate, with a lifetime attributable risk of cancer incidence of about 2 cases per 100,000 persons for each organ [12].